Zealand Pharma A/S
ZLDPF
$40.99
-$0.01-0.02%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 729.97% | 1,093.48% | 27,971.16% | -48.04% | -61.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 729.97% | 1,093.48% | 27,971.16% | -48.04% | -61.42% |
| Cost of Revenue | -100.00% | -- | -95.44% | -91.47% | -96.57% |
| Gross Profit | 769.12% | 377.51% | 38,779.12% | -29.02% | -25.38% |
| SG&A Expenses | -34.98% | 116.26% | 44.11% | 32.13% | 139.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.10% | 54.86% | 161.93% | 48.44% | 52.13% |
| Operating Income | -51.04% | -41.62% | 3,384.00% | -54.13% | -63.01% |
| Income Before Tax | -52.04% | -45.59% | 3,007.76% | -41.83% | -8.80% |
| Income Tax Expenses | -5,106.46% | 2,999.51% | 43,140.49% | 1.42% | 0.36% |
| Earnings from Continuing Operations | -42.07% | -61.31% | 2,827.34% | -42.09% | -8.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.07% | -61.31% | 2,827.34% | -42.09% | -8.82% |
| EBIT | -51.04% | -41.62% | 3,384.00% | -54.13% | -63.01% |
| EBITDA | -51.37% | -41.94% | 3,471.63% | -55.91% | -63.03% |
| EPS Basic | -42.84% | -62.14% | 2,517.38% | -24.03% | 10.19% |
| Normalized Basic EPS | -64.65% | -42.26% | 2,596.02% | -27.84% | 3.42% |
| EPS Diluted | -42.82% | -62.14% | 2,484.19% | -24.03% | 10.17% |
| Normalized Diluted EPS | -64.65% | -42.26% | 2,561.76% | -27.84% | 3.42% |
| Average Basic Shares Outstanding | -0.54% | -0.51% | 12.83% | 14.55% | 21.18% |
| Average Diluted Shares Outstanding | -0.54% | -0.51% | 14.40% | 14.55% | 21.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |